AUSTIN, Texas–(BUSINESS WIRE)–Elevage Medical Technologies (“Elevage” or the “Company”), a strategic growth partner to innovative medical technology companies, today announced that its Board of Directors (the “Board”) has promoted Michael Wasserman, Ph.D., from Chief Operating Officer to Chief Executive Officer, effective immediately. Dr. Wasserman succeeds Evan Melrose, M.D., who has been terminated from all positions relating to Elevage, the Board and the companies with which Elevage has pa

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.